Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-257-1 | CAS number: 56554-53-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 Apr - 18 Jun 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Propane-1,2,3-triyl 3,5,5-trimethylhexanoate
- EC Number:
- 260-257-1
- EC Name:
- Propane-1,2,3-triyl 3,5,5-trimethylhexanoate
- Cas Number:
- 56554-53-1
- Molecular formula:
- C30H56O6
- IUPAC Name:
- 1,3-bis[(3,5,5-trimethylhexanoyl)oxy]propan-2-yl 3,5,5-trimethylhexanoate
Constituent 1
Method
- Target gene:
- his operon for S. typhimurium strains and trp operon for E. coli strain
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbitone/β-naphthoflavone
- Test concentrations with justification for top dose:
- Preliminary toxicity test: 0.15, 0.5, 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation
Experiment 1 (plate incorporation): 50, 150, 500, 1500, 5000 µg/plate with and without metabolic activation
Experiment 2 (pre-incubation): 50, 150, 500, 1500, 5000 µg/plate with and without metabolic activation - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: The test item was immiscible in sterile distilled water and dimethyl sulphoxide at 50 mg/mL but was fully miscible in acetone at 100 mg/ml in solubility checks performed in-house. Acetone was therefore selected as the vehicle.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 20 min (Experiment 2 only)
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: triplicates each in two independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: inspection of the bacterial background lawn - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested.
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data.
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgement about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Mean values and standard deviation were calculated.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: The test item was immiscible in sterile distilled water at 50 mg/ml.
- Precipitation: A test item precipitate (oily in appearance) was observed at and above 1500 µg/plate, this observation did not prevent the scoring of revertant colonies.
- Stability in vehicle: There was no visible change in test item formulations throughout each experiment, therefore, it was assumed to be stable under the test conditions.
RANGE-FINDING/SCREENING STUDIES:
The preliminary toxicity test and Experiment 1 can be considered as range-finding studies. No cytotoxicity and no effects on the number of revertant colonies were observed at any test concentration in both tests. Therefore, in Experiment 2 the test item concentration range was the same as the range-finding tests, i.e. up to the limit concentration of 5000 µg/plate.
COMPARISON WITH HISTORICAL CONTROL DATA:
The number of revertant colonies in the vehicle, untreated and positive controls was within the ranges of the reported history profile of vehicle (combined historical negative and solvent control ranges) and positive control values of the testing facility for the two last calendar years.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
In the preliminary toxicity test, the test item was non-toxic to the strains of bacteria used (TA100 and WP2uvrA). The test item formulation and S9-mix used in this experiment were both shown to be sterile.
No cytotoxic effects (reduction in the growth of the bacterial background lawn) were observed at any concentration in Experiments 1 and 2.
Any other information on results incl. tables
Table 1. Preliminary toxicity test (numbers of revertant colonies).
With (+) or without (-) S9-mix |
Strain |
Dose (µg/plate) |
||||||||||
|
|
0 |
0.15 |
0.5 |
1.5 |
5 |
15 |
50 |
150 |
500 |
1500 |
5000 |
- |
TA100 |
65 |
63 |
69 |
68 |
65 |
66 |
62 |
63 |
63 |
66P |
69P |
+ |
TA100 |
73 |
71 |
62 |
63 |
73 |
64 |
79 |
67 |
69 |
65P |
69P |
- |
WP2uvrA |
29 |
27 |
27 |
25 |
24 |
29 |
31 |
35 |
36 |
33P |
36P |
+ |
WP2uvrA |
43 |
44 |
44 |
41 |
48 |
43 |
27 |
34 |
38 |
46P |
49P |
P: Precipitate
Table 2. Spontaneous mutation rates (concurrent negative controls)
Number of revertants (mean number of colonies per plate) |
||||
Base-pair substitution type |
Frameshift type |
|||
EXPERIMENT 1 (plate incorporation) |
||||
TA 100 |
TA 1535 |
WP2uvrA |
TA 98 |
TA 1537 |
106 99 136 (114) |
23 31 24 (26) |
44 41 28 (38) |
35 28 31 (31) |
11 12 13 (12) |
EXPERIMENT 2 (pre-incubation) |
||||
134 128 110 (124) |
27 20 21 (23) |
57 31 44 (44) |
40 33 25 (33) |
11 15 7 (11) |
Table 3. Test results Experiment 1
EXPERIMENT 1 (plate incorporation) Number of revertants (mean ± standard deviation) |
|||||
S9-Mix |
Without |
||||
Test item (µg/plate) |
TA 100 |
TA 1535 |
WP2uvrA |
TA 98 |
TA1537 |
Solvent control (acetone) |
112 120 138 (123 ± 13.3) |
19 24 17 (20 ± 3.6) |
51 52 40 (48 ± 6.7) |
35 24 36 (32 ± 6.7) |
16 15 16 (16 ± 0.6) |
50 |
114 124 112 (117 ± 6.4) |
17 19 21 (19 ± 2.0) |
37 49 43 (43 ± 6.0) |
32 31 32 (32 ± 0.6) |
16 15 15 (15 ± 0.6) |
150 |
111 114 115 (113 ± 2.1) |
17 17 19 (18 ± 1.2) |
47 43 35 (42 ± 6.1) |
29 27 36 (31 ± 4.7) |
15 16 17 (16 ± 1.0) |
500 |
120 122 130 (124 ± 5.3) |
17 16 23 (19 ± 3.8) |
43 41 44 (43 ± 1.5) |
29 27 21 (26 ± 4.2) |
19 19 17 (18 ± 1.2) |
1500 |
134 P 120 P 110 P (121 ± 12.1) |
25 P 17 P 24 P (22 ± 4.4) |
40 P 52 P 41 P (44 ± 6.7) |
31 P 31 P 20 P (27 ± 6.4) |
11 P 8 P 12 P (10 ± 2.1) |
5000 |
123 P 114 P 111 P (116 ± 6.2) |
24 P 13 P 13 P (17 ± 6.4) |
39 P 33 P 33 P (35 ± 3.5) |
29 P 24 P 29 P (27 ± 2.9) |
16 P 9 P 8 P (11 ± 4.4) |
ENNG |
649 549 575 (591 ± 51.9) |
640 678 1024 (781 ± 211.6) |
942 1016 956 (971 ± 39.3) |
- |
- |
4NQO |
- |
- |
- |
167 174 158 (166 ± 8.0) |
- |
9AA |
- |
- |
- |
- |
474 289 516 (426 ± 120.8) |
|
|||||
S9-Mix |
With |
||||
Test item (µg/plate) |
TA 100 |
TA 1535 |
WP2uvrA |
TA 98 |
TA1537 |
Solvent control (acetone) |
95 119 86 (100 ± 17.1) |
11 5 13 (10 ± 4.2) |
55 49 55 (53 ± 3.5) |
27 27 33 (29 ± 3.5) |
15 13 17 (15 ± 2.0) |
50 |
102 69 116 (96 ± 24.1) |
19 8 13 (13 ± 5.5) |
55 41 49 (48 ± 7.0) |
27 24 29 (27 ± 2.5) |
12 19 16 (16 ± 3.5) |
150 |
90 131 103 (108 ± 21.0) |
13 17 8 (13 ± 4.5) |
48 43 48 (46 ± 2.9) |
27 35 37 (33 ± 5.3) |
12 8 11 (10 ± 2.1) |
500 |
123 79 91 (98 ± 22.7) |
15 16 13 (15 ± 1.5) |
48 52 53 (51 ± 2.6) |
27 25 27 (26 ± 1.2) |
15 16 17 (16 ± 1.0) |
1500 |
90 P 112 P 99 P (100 ± 11.1) |
15 P 9 P 15 P (13 ± 3.5) |
44 P 47 P 48 P (46 ± 2.1) |
39 P 25 P 25 P (30 ± 8.1) |
15 P 12 P 19 P (15 ± 3.5) |
5000 |
106 P 103 P 103 P (104 ± 1.7) |
9 P 15 P 9 P (11 ± 3.5) |
48 P 43 P 43 P (45 ± 2.9) |
31 P 31 P 29 P (30 ± 1.2) |
13 P 15 P 15 P (14 ± 1.2) |
2AA |
1407 1922 1370 (1566 ± 308.6) |
238 253 243 (245 ± 7.6) |
513 537 581 (544 ± 34.5) |
- |
249 385 295 (310 ± 69.2) |
BP |
- |
- |
- |
200 262 210 (224 ± 33.3) |
- |
ENNG: N-ethyl-N'-nitro-N-nitrosoguanidine: 2 µg/plate for WP2uvrA, 3 µg/plate for TA100, 5 µg/plate for TA1535
9AA: 9-Aminoacridine: 80 µg/plate for TA1537
4NQO: 4-Nitroquinoline-1-oxide: 0.2 µg/plate for TA98
2AA: 2-Aminoanthracene: 1 µg/plate for TA100, 2 µg/plate for TA1535 and TA1537, 10 µg/plate for WP2uvrA
BP: Benzo(a)pyrene: 5 µg/plate for TA98
P: Precipitate
Table 4. Test results Experiment 2
EXPERIMENT 2 (pre-incubation) Number of revertants (mean ± standard deviation) |
|||||
S9-Mix |
Without
|
||||
Test item (µg/plate) |
TA 100 |
TA 1535 |
WP2uvrA |
TA 98 |
TA1537 |
Solvent control (acetone) |
118 132 114 (121 ± 9.5) |
25 23 25 (24 ± 1.2) |
57 27 21 (35 ± 19.3) |
35 41 33 (36 ± 4.2) |
17 8 13 (13 ± 4.5) |
50 |
112 119 120 (117 ± 4.4) |
19 27 13 (20 ± 7.0) |
40 35 49 (41 ± 7.1) |
25 41 27 (31 ± 8.7) |
13 12 7 (11 ± 3.2) |
150 |
114 111 122 (116 ± 5.7) |
21 24 17 (21 ± 3.5) |
41 31 41 (38 ± 5.8) |
23 32 15 (23 ± 8.5) |
11 8 12 (10 ± 2.1) |
500 |
124 127 136 (129 ± 6.2) |
28 29 29 (29 ± 0.6) |
41 37 43 (40 ± 3.1) |
31 28 31 (30 ± 1.7) |
9 13 4 (9 ± 4.5) |
1500 |
115 P 126 P 126 P (122 ± 6.4) |
23 P 25 P 20 P (23 ± 2.5) |
39 P 39 P 32 P (37 ± 4.0) |
31 P 29 P 33 P (31 ± 2.0) |
9 P 16 P 12 P (12 ± 3.5) |
5000 |
107 P 104 P 116 P (109 ± 6.2) |
16 P 31 P 19 P (22 ± 7.9) |
31 P 49 P 49 P (43 ± 10.4) |
33 P 35 P 23 P (30 ± 6.4) |
17 P 8 P 13 P (13 ± 4.5) |
ENNG |
448 453 502 (468 ± 29.8) |
233 192 231 (219 ± 23.1) |
541 492 501 (511 ± 26.1) |
- |
- |
4NQO |
- |
- |
- |
158 140 106 (135 ± 26.4) |
- |
9AA |
- |
- |
- |
- |
604 442 535 (527 ± 81.3) |
|
|||||
S9-Mix |
With |
||||
Test item (µg/plate) |
TA 100 |
TA 1535 |
WP2uvrA |
TA 98 |
TA1537 |
Solvent control (acetone) |
130 132 128 (130 ± 2.0) |
9 9 23 (14 ± 8.1) |
53 59 41 (51 ± 9.2) |
32 29 33 (31 ± 2.1) |
12 8 12 (11 ± 2.3) |
50 |
120 114 115 (116 ± 3.2) |
13 13 21 (16 ± 4.6) |
39 49 41 (43 ± 5.3) |
27 41 31 (33 ± 7.2) |
8 19 19 (15 ± 6.4) |
150 |
130 134 116 (127 ± 9.5) |
17 17 15 (16 ± 1.2) |
44 48 56 (49 ± 6.1) |
45 33 40 (39 ± 6.0) |
16 20 9 (15 ± 5.6) |
500 |
114 124 135 (124 ± 10.5) |
16 9 8 (11 ± 4.4) |
53 48 53 (51 ± 2.9) |
25 32 39 (32 ± 7.0) |
17 19 16 (17 ± 1.5) |
1500 |
123 P 118 P 108 P (116 ± 7.6) |
9 P 9 P 8 P (9 ± 0.6) |
45 P 43 P 43 P (44 ± 1.2) |
37 P 39 P 33 P (36 ± 3.1) |
15 P 23 P 13 P (17 ± 5.3) |
5000 |
122 P 126 P 115 P (121 ± 5.6) |
12 P 11 P 8 P (10 ± 2.1) |
51 P 49 P 49 P (50 ± 1.2) |
35 P 32 P 31 P (33 ± 2.1) |
11 P 15 P 19 P (15 ± 4.0) |
2AA |
1270 1262 1407 (1313 ± 81.5) |
184 212 234 (210 ± 25.1) |
275 255 350 (293 ± 50.1) |
- |
279 277 289 (282 ± 6.4) |
BP |
- |
- |
- |
176 204 203 (194 ± 15.9) |
- |
ENNG: N-ethyl-N'-nitro-N-nitrosoguanidine: 2 µg/plate for WP2uvrA, 3 µg/plate for TA100, 5 µg/plate for TA1535
9AA: 9-Aminoacridine: 80 µg/plate for TA1537
4NQO: 4-Nitroquinoline-1-oxide: 0.2 µg/plate for TA98
2AA: 2-Aminoanthracene: 1 µg/plate for TA100, 2 µg/plate for TA1535 and TA1537, 10 µg/plate for WP2uvrA
BP: Benzo(a)pyrene: 5 µg/plate for TA98
P: Precipitate
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)